At soup kitchens, clothing centers and shelters, alums, staff and students pitch in to show that Cornell Cares

More than 300 Cornell volunteers helped at soup kitchens, community centers, homeless shelters and other projects, led in many instances by current students, as part of the 'Big Red in the Big Apple' celebration. (Jan. 28, 2008)

Cornell Cares Day unites students, alums for a day of community service

Alumni and Cornell students came together in 17 U.S. cities and in Shanghai, China, Jan. 5-6, for Cornell Cares Day, tackling community service projects and connecting with other Cornellians. (Jan. 9, 2008)

President Skorton congratulates NewYork-Presbyterian Hospital's staff, leadership for honor roll ranking

Cornell President David Skorton congratulates the staff and academic leadership of NewYork-Presbyterian Hospital for its sixth-place ranking in the U.S. News and World Report 'America's Best Hospitals' survey.

New procedure offers hope to patients at high risk for recurrent stroke

Surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are the first in the New York City metropolitan area to successfully implant into the brain arteries a new stent specifically designed to treat high-risk stroke patients.

Electrocardiogram helps predict risk for congestive heart failure in hypertensive patients

An electrocardiogram is an effective tool for detecting risk of congestive heart failure (CHF) in patients with hypertension, according to a new study by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

NewYork-Presbyterian/Weill Cornell research brings new insights, hope for the treatment of male infertility

New research is expanding what we know about the causes, diagnosis, and treatment of infertility in men. A team from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City demonstrated the effectiveness of microsurgical sperm extraction and intracytoplasmic sperm injection (ICSI).

Weill Cornell/ludwig institute for cancer research collaboration identifies two antigens as targets for multiple myeloma vaccine

Vaccines that train the immune system to seek out and destroy malignant cells are at the cutting edge of cancer treatment. Now, joint research – conducted by researchers at Weill Medical Cornell and at the Ludwig Institute for Cancer Research Memorial Sloan-Kettering Cancer Center Branch in New York – has pinpointed two proteins that seem ideal targets for a vaccine against multiple myeloma.

Silencing human gene through new science of epigenetics

For the first time, scientists have shown how the activity of a gene associated with normal human development, as well as the occurrence of cancer and several other diseases, is repressed epigenetically – by modifying not the DNA code of a gene, but instead the spool-like histone proteins around which DNA tightly wraps itself in the nucleus of cells in the body.

New York Weill Cornell's Rare GEM Program Makes Homes Livable for the Elderly

It doesn't take much imagination to see that preventing falls, brightening dark and depressing spaces, and generally making environments habitable can be among the most important elements for improving the health of the elderly.